Try a new search

Format these results:

Searched for:

Department/Unit:Cell Biology

Total Results:

14241


De novo design of obligate ABC-type heterotrimeric proteins

Bermeo, Sherry; Favor, Andrew; Chang, Ya-Ting; Norris, Andrew; Boyken, Scott E; Hsia, Yang; Haddox, Hugh K; Xu, Chunfu; Brunette, T J; Wysocki, Vicki H; Bhabha, Gira; Ekiert, Damian C; Baker, David
The de novo design of three protein chains that associate to form a heterotrimer (but not any of the possible two-chain heterodimers) and that can drive the assembly of higher-order branching structures is an important challenge for protein design. We designed helical heterotrimers with specificity conferred by buried hydrogen bond networks and large aromatic residues to enhance shape complementary packing. We obtained ten designs for which all three chains cooperatively assembled into heterotrimers with few or no other species present. Crystal structures of a helical bundle heterotrimer and extended versions, with helical repeat proteins fused to individual subunits, showed all three chains assembling in the designed orientation. We used these heterotrimers as building blocks to construct larger cyclic oligomers, which were structurally validated by electron microscopy. Our three-way junction designs provide new routes to complex protein nanostructures and enable the scaffolding of three distinct ligands for modulation of cell signaling.
PMCID:9758053
PMID: 36522429
ISSN: 1545-9985
CID: 5382412

The role of KRAS splice variants in cancer biology

Nuevo-Tapioles, Cristina; Philips, Mark R
The three mammalian RAS genes (HRAS, NRAS and KRAS) encode four proteins that play central roles in cancer biology. Among them, KRAS is mutated more frequently in human cancer than any other oncogene. The pre-mRNA of KRAS is alternatively spliced to give rise to two products, KRAS4A and KRAS4B, which differ in the membrane targeting sequences at their respective C-termini. Notably, both KRAS4A and KRAS4B are oncogenic when KRAS is constitutively activated by mutation in exon 2 or 3. Whereas KRAS4B is the most studied oncoprotein, KRAS4A is understudied and until recently considered relatively unimportant. Emerging work has confirmed expression of KRAS4A in cancer and found non-overlapping functions of the splice variants. The most clearly demonstrated of these is direct regulation of hexokinase 1 by KRAS4A, suggesting that the metabolic vulnerabilities of KRAS-mutant tumors may be determined in part by the relative expression of the splice variants. The aim of this review is to address the most relevant characteristics and differential functions of the KRAS splice variants as they relate to cancer onset and progression.
PMCID:9663995
PMID: 36393833
ISSN: 2296-634x
CID: 5384892

Telomere fusions as a signal of term placental aging? A pilot study

Kohlrausch, Fabiana B; Wang, Fang; Luo, Danxia; Mahn, Rebecca; Keefe, David L
The placenta plays an essential role at the beginning of life, nourishing and supporting the fetus, but its life span is limited. In late pregnancy, the placenta develops signs of aging, including inflammation and impaired function, which may complicate pregnancy. Placentas also show another sign of aging - cells with extra or missing chromosomes. Chromosomally abnormal cells could gather in the placenta if they get stranded there and/or if the cells do not separate normally. Chromosome separation goes wrong in aging cells when the DNA sequences, which protect the ends of the chromosomes, erode. When chromosomes lose their protective caps, they fuse which leads to abnormal numbers of chromosomes. In this pilot study, for the first time, we found fusions between the caps in a human placenta when it reaches full term. More studies are needed to decide whether this has an influence on how the placenta works and outcomes of pregnancy.
PMID: 36374285
ISSN: 2633-8386
CID: 5381622

Linking single nucleotide polymorphisms to signaling blueprints in abdominal aortic aneurysms

Lim, Chrysania; Pratama, Muhammad Yogi; Rivera, Cristobal; Silvestro, Michele; Tsao, Philip S; Maegdefessel, Lars; Gallagher, Katherine A; Maldonado, Thomas; Ramkhelawon, Bhama
Abdominal aortic aneurysms (AAA) is a multifactorial complex disease with life-threatening consequences. While Genome-wide association studies (GWAS) have revealed several single nucleotide polymorphisms (SNPs) located in the genome of individuals with AAA, the link between SNPs with the associated pathological signals, the influence of risk factors on their distribution and their combined analysis is not fully understood. We integrated 86 AAA SNPs from GWAS and clinical cohorts from the literature to determine their phenotypical vulnerabilities and association with AAA risk factors. The SNPs were annotated using snpXplorer AnnotateMe tool to identify their chromosomal position, minor allele frequency, CADD (Combined Annotation Dependent Depletion), annotation-based pathogenicity score, variant consequence, and their associated gene. Gene enrichment analysis was performed using Gene Ontology and clustered using REVIGO. The plug-in GeneMANIA in Cytoscape was applied to identify network integration with associated genes and functions. 15 SNPs affecting 20 genes with a CADD score above ten were identified. AAA SNPs were predominantly located on chromosome 3 and 9. Stop-gained rs5516 SNP obtained high frequency in AAA and associated with proinflammatory and vascular remodeling phenotypes. SNPs presence positively correlated with hypertension, dyslipidemia and smoking history. GO showed that AAA SNPs and their associated genes could regulate lipid metabolism, extracellular matrix organization, smooth muscle cell proliferation, and oxidative stress, suggesting that part of these AAA traits could stem from genetic abnormalities. We show a library of inborn SNPs and associated genes that manifest in AAA. We uncover their pathological signaling trajectories that likely fuel AAA development.
PMCID:9722707
PMID: 36470918
ISSN: 2045-2322
CID: 5378652

Novel alendronate-CGS21680 conjugate reduces bone resorption and induces new bone formation in post-menopausal osteoporosis and inflammatory osteolysis mouse models

Larrañaga-Vera, Ane; Toti, Kiran S; Flatow, James S; Haraczy, Alexandra J; Warnick, Eugene; Rao, Harsha; Gao, Zhan-Guo; Sussman, Sarah M; Mediero, Aranzazu; Leucht, Philipp; Jacobson, Kenneth A; Cronstein, Bruce N
Loss of bone is a common medical problem and, while it can be treated with available therapies, some of these therapies have critical side effects. We have previously demonstrated that CGS21680, a selective A2A adenosine receptor agonist, prevents bone loss, but its on-target toxicities (hypotension, tachycardia) and frequent dosing requirements make it unusable in the clinic. We therefore generated a novel alendronate-CGS21680 conjugate (MRS7216), to target the agonist to bone where it remains for long periods thereby diminishing the frequency of administration and curtailing side effects. MRS7216 was synthesized from CGS21680 by sequential activation of the carboxylic acid moiety and reacting with an appropriate amino acid (PEG, alendronic acid) under basic conditions. MRS7216 was tested on C57BL/6J (WT) mice with established osteoporosis (OP) and WT or A2A KO mice with wear particle-induced inflammatory osteolysis (OL). Mice were treated weekly with MRS7216 (10mg/kg). Bone formation was studied after in vivo labeling with calcein/Alizarin Red, and μCT and histology analyses were performed. In addition, human primary osteoblasts and osteoclasts were cultured using bone marrow discarded after hip replacement. Receptor binding studies demonstrate that MRS7216 efficiently binds the A2A adenosine receptor. MRS7216-treated OP and OL mice had significant new bone formation and reduced bone loss compared to vehicle or alendronate-treated mice. Histological analysis showed that MRS7216 treatment significantly reduced osteoclast number and increased osteoblast number in murine models. Interestingly, cultured human osteoclast differentiation was inhibited, and osteoblast differentiation was stimulated by the compound indicating that MRS7216 conjugates represent a novel therapeutic approach to treat osteoporosis and osteolysis.
PMCID:9733060
PMID: 36494860
ISSN: 1478-6362
CID: 5378892

Specific and common functional connectivity deficits in drug-free generalized anxiety disorder and panic disorder: A data-driven analysis

Li, Wei; Cui, Huiru; Li, Hui; Colcombe, Stan; Smith, Robert C; Cao, Xinyi; Pang, Jiaoyan; Hu, Qiang; Zhang, Lanlan; Yang, Zhi; Wang, Jijun; Li, Chunbo
Evidence of comparing neural network differences between anxiety disorder subtypes is limited, while it is crucial to reveal the pathogenesis of anxiety disorders. The present study aimed to investigate specific and common resting-state functional connectivity (FC) networks in generalized anxiety disorder (GAD), panic disorder (PD), and healthy controls (HC). We employed the gRAICAR algorithm to decompose the resting-state fMRI into independent components and align the components across 61 subjects (22 GAD, 18 PD and 21 HC). The default mode network and precuneus network exhibited GAD-specific aberrance, the anterior default mode network showed atypicality specific to PD, and the right fronto-parietal network showed aberrance common to GAD and PD. Between GAD-specific networks, FC between bilateral dorsolateral prefrontal cortex (DLPFC) was positively correlated with interoceptive sensitivity. In the common network, altered FCs between DLPFC and angular gyrus, and between orbitofrontal cortex and precuneus, were positively correlated with anxiety severity and interoceptive sensitivity. The pathological mechanism of PD could closely relate to the dysfunction of prefrontal cortex, while GAD could involve more extensive brain areas, which may be related to fear generalization.
PMID: 36459805
ISSN: 1872-7123
CID: 5374172

Galectin-9: A novel promoter of atherosclerosis progression

Krautter, Franziska; Hussain, Mohammed T; Zhi, Zhaogong; Lezama, Danielle R; Manning, Julia E; Brown, Emily; Marigliano, Noemi; Raucci, Federica; Recio, Carlota; Chimen, Myriam; Maione, Francesco; Tiwari, Alok; McGettrick, Helen M; Cooper, Dianne; Fisher, Edward A; Iqbal, Asif J
BACKGROUND AND AIMS/OBJECTIVE:Atherosclerosis is widely accepted to be an inflammatory disease driven by lipid accumulation and leukocyte recruitment. More recently, galectins, a family of β-galactoside binding proteins, have been shown to play a role in leukocyte recruitment among other immunomodulatory functions. Galectin (Gal) -9, a tandem repeat type galectin expressed by the endothelium in inflammatory environments, has been proposed to promote leukocyte recruitment. However, the role of Gal-9 in the context of monocyte recruitment remains elusive. METHODS AND RESULTS/RESULTS:monocytes in a β2-integrin and glycan dependent manner, while adhesion of monocytes to stimulated endothelium is reduced when Gal-9 is knocked down. Gal-9 also facilitates enhanced recruitment of leukocytes from peripheral arterial disease (PAD) patients compared to healthy young and aged controls. We further characterise the endothelium as source of circulating Gal-9, which is increased in plasma of PAD patients compared to healthy controls. CONCLUSIONS:These results highlight a pathological role for Gal-9 as promoter of monocyte recruitment and atherosclerotic plaque progression, making it a novel target in the prevention of plaque formation and progression.
PMID: 36459823
ISSN: 1879-1484
CID: 5374182

Plasmodium falciparum and TNF-α Differentially Regulate Inflammatory and Barrier Integrity Pathways in Human Brain Endothelial Cells

Zuniga, Marisol; Gomes, Claudia; Chen, Ze; Martinez, Criseyda; Devlin, Joseph Cooper; Loke, P'ng; Rodriguez, Ana
Cerebral malaria is a severe complication of Plasmodium falciparum infection characterized by the loss of blood-brain barrier (BBB) integrity, which is associated with brain swelling and mortality in patients. P. falciparum-infected red blood cells and inflammatory cytokines, like tumor necrosis factor alpha (TNF-α), have been implicated in the development of cerebral malaria, but it is still unclear how they contribute to the loss of BBB integrity. Here, a combination of transcriptomic analysis and cellular assays detecting changes in barrier integrity and endothelial activation were used to distinguish between the effects of P. falciparum and TNF-α on a human brain microvascular endothelial cell (HBMEC) line and in primary human brain microvascular endothelial cells. We observed that while TNF-α induced high levels of endothelial activation, it only caused a small increase in HBMEC permeability. Conversely, P. falciparum-infected red blood cells (iRBCs) led to a strong increase in HBMEC permeability that was not mediated by cell death. Distinct transcriptomic profiles of TNF-α and P. falciparum in HBMECs confirm the differential effects of these stimuli, with the parasite preferentially inducing an endoplasmic reticulum stress response. Our results establish that there are fundamental differences in the responses induced by TNF-α and P. falciparum on brain endothelial cells and suggest that parasite-induced signaling is a major component driving the disruption of the BBB during cerebral malaria, proposing a potential target for much needed therapeutics. IMPORTANCE Cerebral malaria is a severe complication of Plasmodium falciparum infection that causes the loss of blood-brain barrier integrity and frequently results in death. Here, we compared the effect of P. falciparum-infected red blood cells and inflammatory cytokines, like TNF-α, in the loss of BBB integrity. We observed that while TNF-α induced a small increase in barrier permeability, P. falciparum-infected red blood cells led to a severe loss of barrier integrity. Our results establish that there are fundamental differences in the responses induced by TNF-α and P. falciparum on brain endothelial cells and suggest that parasite-induced signaling is a major component driving the disruption of the BBB during cerebral malaria, proposing a potential target for much needed therapeutics.
PMCID:9601155
PMID: 36036514
ISSN: 2150-7511
CID: 5371222

VITRIFICATION WITH DIMETHYL SULFOXIDE (DMSO) CRYOPROTECTANT ALTERS GENE AND TRANSPOSABLE ELEMENT (TE) EXPRESSION IN HUMAN OOCYTES [Meeting Abstract]

Wiltshire, A M; Schaal, R F; WANG, F; Tsou, T; McKerrow, W; Keefe, D L
Objective: DMSO alters the epigenetic state of mouse oocytes and human cultured cells. The effect of vitrification with DMSO containing cryoprotectant on gene and TE expression in human oocytes is unknown.
Material(s) and Method(s): A prospective paired controlled cohort laboratory study was performed from February - June 2021. Twenty-four discarded oocytes in the germinal vesical (GV) stage were donated from four patients. All oocytes were paired such that half of the oocytes from each patient were vitrified with DMSO-containing cryoprotectant, while the other half were frozen, unexposed to DMSO. All oocytes underwent RNA sequencing via Switching Mechanism At the end of the 5'-end of the RNA Transcript sequencing 2 (SMARTseq2). Reads containing adapters, bases that could not be determined >10% and low quality reads were excluded. Gene mapping to the human reference genome, followed by gene quantification, were performed. Next, differential gene expression analysis between the two cohorts was performed. Then functional enrichment analyses of dysregulated gene sets were performed with Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG), and Human Disease Ontology (DO). Raw data obtained from RNA sequencing was used to analyze TE transcripts using the BonaFide-TEseq method, which were mapped to specific TE loci using Software for Quantifying Interspersed Repeat Expression (SQuIRE), to identify differentially expressed TEs. Real time-qPCR validated results of selected genes and TEs.
Result(s): Of the 27,837 genes identified by SMARTseq2, 7,331 (26.3%) were differentially expressed (p<0.05). Specifically, 3,987 genes were upregulated and 3,344 genes were downregulated in oocytes exposed to DMSO. Genes involved in chromatin and histone modification, and mitochondrial function, as well as WNT, insulin, MTOR, HIPPO and MAPK signaling pathways were affected by DMSO. There was no significant over expression of human disease ontology terms within our data set. Expression of a number of TEs was also affected by exposure to DMSO, including Alu, endogenous retrovirus family members 1 and K (ERV1, ERVK) and long interspersed nuclear elements 1 (LINE-1). Notably, the effects of DMSO on TE expression were most pronounced in the oldest patient. The expression of TEs was negatively correlated with age, and positively correlated with the expression of PIWI-like protein 2 (PIWIL2), DNA Methyltransferase (DNMT) 3A and 3B.
Conclusion(s): Vitrification with DMSO exposure leads to significant changes in gene and TE expression in human GV oocytes. Future experiments should determine whether MII oocytes respond similarly. Impact Statement: Oocyte vitrification with DMSO containing cryoprotectant induces significant transcriptome changes, including those involving TEs, in human GV oocytes. Further studies are needed to evaluate the clinical significance of these findings. Support: This study was supported by the Stanley H Kaplan Fund.
Copyright
EMBASE:2020861203
ISSN: 1556-5653
CID: 5366962

Mechanical overloading induces GPX4-regulated chondrocyte ferroptosis in osteoarthritis via Piezo1 channel facilitated calcium influx

Wang, Shaoyi; Li, Weiwei; Zhang, Pengfei; Wang, Zihao; Ma, Xiaoyuan; Liu, Chuanju; Vasilev, Krasimir; Zhang, Lei; Zhou, Xiaocong; Liu, Liang; Hayball, John; Dong, Shuli; Li, Yuhua; Gao, Yuan; Cheng, Lei; Zhao, Yunpeng
INTRODUCTIONS:Excessive mechanical stress is closely associated with cell death in various conditions. Exposure of chondrocytes to excessive mechanical loading leads to a catabolic response as well as exaggerated cell death. Ferroptosis is a recently identified form of cell death during cell aging and degeneration. However, it's potential association with mechanical stress remains to be illustrated. OBJECTIVES:To identify whether excessive mechanical stress can cause ferroptosis. To explore the role of mechanical overloading in chondrocyte ferroptosis. METHODS:) mice OA model and chondrocytes cultured with high strain mechanical stress. Furthermore, the role of Piezo1 ion channel in chondrocyte ferroptosis and OA development was explored by using its inhibitor (GsMTx4) and agonist (Yoda1). Additionally, chondrocyte was cultured in calcium-free medium with mechanical stress, and ferroptosis phenotype was tested. RESULTS:Human cartilage and mouse chondrocyte experiments revealed that mechanical overloading can induce GPX4-associated ferroptosis. Conditional knockout of GPX4 in cartilage aggravated experimental OA process, while additional treatment with ferroptosis suppressor protein (FSP-1) and coenzyme Q10 (CoQ10) abated OA development in GPX4-CKO mice. In mouse OA model and chondrocyte experiments, inhibition of Piezo1 channel activity increased GPX4 expression, attenuated ferroptosis phenotype and reduced the severity of osteoarthritis. Additionally, high strain mechanical stress induced ferroptosis damage in chondrocyte was largely abolished by blocking calcium influx through calcium-free medium. CONCLUSIONS:Our findings show that mechanical overloading induces ferroptosis through Piezo1 activation and subsequent calcium influx in chondrocytes, which might provide a potential target for OA treatment.
PMCID:9637484
PMID: 36328754
ISSN: 2090-1224
CID: 5356842